Cognitive Impairment clinical trials at UC Irvine
2 in progress, 1 open to eligible people
Biomarker Exploration in Aging, Cognition and Neurodegeneration
open to eligible people ages 60 years and up
The purpose of this research study is to understand the factors that underlie changes in thinking and memory with increasing age. The investigators will test the usefulness of MRI, PET, and cognitive testing in detecting subtle changes in the brain…
Irvine, California
NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
Sorry, not yet accepting patients
This is a phase I, dose-escalation and phase II dose-expansion clinical trial determining the maximum tolerated dose (MTD) and safety and tolerability of adding N-Acetyl-Cysteine (NAC) to ovarian cancer patients who are receiving a platinum-based…
Our lead scientists for Cognitive Impairment research studies include Michael A Yassa, PhD Daniela A. Bota.
Last updated: